Tianhong Li

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Topics

Small Cell Lung Cancer

Tyrosine Kinase

Liver Metastases

Squamous Cell Carcinoma

Top Venues

Molecular cancer therapeutics

Clinical cancer research : an official journal of the American Association for Cancer Research

Clinical & experimental metastasis

This page only lists publications with an associated author ORCID identifier.

Publications

Daniel Morgensztern, Neal E Ready, Melissa Lynne Johnson, Afshin Dowlati, Noura J Choudhury, David P Carbone, Eric Schaefer, Susanne M Arnold, Sonam Puri, Zofia Piotrowska, Aparna Hegde, Anne C Chiang, Wade T Iams, Anthony W Tolcher, Kaname Nosaki, Toshiyuki Kozuki, Tianhong Li, Rafael Santana-Davila, Hiroaki Akamatsu, Haruyasu Murakami, Hiroshi Yokouchi, Song Wang, Jiuhong Zha, Rui Li, Randy R Robinson, Pooja Hingorani, Edwin E Jeng, Muhammad Furqan
A Phase I First-in-Human Study of ABBV-011, a Seizure-Related Homolog Protein 6-Targeting Antibody-Drug Conjugate, in Patients With Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Weijie Ma, Sixi Wei, Qianping Li, Jie-Zeng Yu, Wenwu Xiao, Chihong Heidi Zhou, Ken Y Yoneda, Amir A Zeki, Tianhong Li
Simvastatin Overcomes Resistance to Tyrosine Kinase Inhibitors in Patient-derived, Oncogene-driven Lung Adenocarcinoma Models. Molecular cancer therapeutics 23 (5) (2024)
Weijie Ma, Sixi Wei, Qianping Li, Jie-Zeng Yu, Wenwu Xiao, Chihong Heidi Zhou, Ken Y Yoneda, Amir A Zeki, Tianhong Li
Simvastatin Overcomes Resistance to Tyrosine Kinase Inhibitors in Patient-derived, Oncogene-driven Lung Adenocarcinoma Models. Molecular cancer therapeutics 23 (5) (2024)
Tianhong Li, Weijie Ma, Ebaa Al-Obeidi
Evolving Precision First-Line Systemic Treatment for Patients with Unresectable Non-Small Cell Lung Cancer. Cancers 16 (13) (2024)
Tianhong Li, Weijie Ma, Ebaa Al-Obeidi
Evolving Precision First-Line Systemic Treatment for Patients with Unresectable Non-Small Cell Lung Cancer. Cancers 16 (13) (2024)
Weijie Ma, Sixi Wei, Qianping Li, Jie-Zeng Yu, Wenwu Xiao, Chihong Heidi Zhou, Ken Y Yoneda, Amir A Zeki, Tianhong Li
Simvastatin overcomes resistance to tyrosine kinase inhibitors in patient-derived, oncogene-driven lung adenocarcinoma models. Molecular cancer therapeutics (2024)
Weijie Ma, Sixi Wei, Qianping Li, Jie-Zeng Yu, Wenwu Xiao, Chihong Heidi Zhou, Ken Y Yoneda, Amir A Zeki, Tianhong Li
Simvastatin Overcomes Resistance to Tyrosine Kinase Inhibitors in Patient-derived, Oncogene-driven Lung Adenocarcinoma Models. Molecular cancer therapeutics 23 (5) (2024)
Weijie Ma, Sixi Wei, Qianping Li, Jie-Zeng Yu, Wenwu Xiao, Chihong Heidi Zhou, Ken Y Yoneda, Amir A Zeki, Tianhong Li
Simvastatin Overcomes Resistance to Tyrosine Kinase Inhibitors in Patient-derived, Oncogene-driven Lung Adenocarcinoma Models. Molecular cancer therapeutics 23 (5) (2024)
Weijie Ma, Jie Zeng, Dennis J Montoya, Kyra Toomey, Chihong Zhou, Shuai Chen, Dingning Liu, Michael Babich, James A Radosevich, Tianhong Li
Labyrinthin Expression Is Associated with Poor Prognosis in Patients with Non-Small-Cell Lung Cancer. Cancers 15 (3) (2023)
Weijie Ma, Jie Zeng, Dennis J Montoya, Kyra Toomey, Chihong Zhou, Shuai Chen, Dingning Liu, Michael Babich, James A Radosevich, Tianhong Li
Labyrinthin Expression Is Associated with Poor Prognosis in Patients with Non-Small-Cell Lung Cancer. Cancers 15 (3) (2023)
Arta M Monjazeb, Megan E Daly, Guilluame Luxardi, Emanual Maverakis, Alexander A Merleev, Alina I Marusina, Alexander D Borowsky, Amin Mirhadi, Stephen L Shiao, Laurel Beckett, Shuai Chen, David Eastham, Tianhong Li, Logan V Vick, Heather M McGee, Frances Lara, Leslie Garcia, Leigh Anne Morris, Robert J Canter, Jonathan W Riess, Kurt A Schalper, William J Murphy, Karen Kelly
Atezolizumab plus stereotactic ablative radiotherapy for medically inoperable patients with early-stage non-small cell lung cancer: a multi-institutional phase I trial. Nature communications 14 (1) (2023)
Weijie Ma, Brian Pham, Tianhong Li
Cancer neoantigens as potential targets for immunotherapy. Clinical & experimental metastasis (2021)
Weijie Ma, Jie Zeng, Shuai Chen, Yue Lyu, Kyra A Toomey, Chinh T Phan, Ken Y Yoneda, Tianhong Li
Small molecule tyrosine kinase inhibitors modulated blood immune cell counts in patients with oncogene-driven NSCLC. Biomarker research 9 (1) (2021)
Julia K Rotow, Philippe Gui, Wei Wu, Victoria M Raymond, Richard B Lanman, Frederic J Kaye, Nir Peled, Ferran Fece de la Cruz, Brandon A Nadres, Ryan B Corcoran, Iwei Yeh, Boris C Bastian, Petr Starostik, Kimberly Newsom, Victor R Olivas, Alexander M Wolff, Brian K Shoichet, Eric A Collisson, Caroline E McCoach, D Ross Camidge, Jose Pacheco, Lyudmila Bazhenova, Tianhong Li, Trever G Bivona, Collin M Blakely
Co-occurring Alterations in the RAS-MAPK Pathway Limit Response to MET Inhibitor Treatment in MET Exon 14 Skipping Mutation-Positive Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (2) (2019)